Eli S Rosenberg1, Gregorio A Millett1, Patrick S Sullivan1, Carlos Del Rio1, James W Curran1. 1. Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, USA (E Rosenberg PhD, Prof P Sullivan PhD, Prof J Curran MD); amfAR, The Foundation for AIDS Research, Washington DC, USA (G Millett MPH); Hubert Department of Global Health, Emory University Rollins School of Public Health and Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, USA (Prof C del Rio MD).
Abstract
BACKGROUND: Black/white disparities in HIV incidence and prevalence among men who have sex with men (MSM) in the United States remain largely unexplained. We examined the impact on HIV prevalence and incidence of interventions that decrease disparities in HIV care. Deciding which interventions have most impact on reducing disparities is critical. METHODS: Using available US Centers for Disease Control and Prevention (CDC) estimates, we constructed HIV care continua for black and white MSM for 2009-2010. These estimates were used as parameters in a deterministic model to yield estimated race-specific transmissions, transmission rates, incidence rates, and rate-ratios (RR). We examined the impact of changes in the care continuum for black MSM on transmission and incidence rates. FINDINGS: Marked disparities were found throughout the care continuum: ultimately, 16% of black and 34% of white MSM achieved viral suppression. Based on these care continua, 9,833 and 9,710 new HIV transmissions were estimated annually respectively from HIV-positive black and white MSM (transmission RR=1·36 and incidence RR=7·92). In a model where black and white MSM have identical care outcomes, transmission RR=1·00 and incidence RR=5·80. Scenarios of 95% diagnosis, 95% retention, and concurrent 95% diagnosis and 95% retention respectively yield transmission RR=1·00, 1·02, 0·56, and incidence RR=5·81, 5·93, 3·28. INTERPRETATION: Disparities in HIV transmission rates may be reduced by improving the HIV care continuum outcomes, but existing racial disparities in HIV prevalence will likely continue to drive higher incidence among black MSM for decades to come.
BACKGROUND: Black/white disparities in HIV incidence and prevalence among men who have sex with men (MSM) in the United States remain largely unexplained. We examined the impact on HIV prevalence and incidence of interventions that decrease disparities in HIV care. Deciding which interventions have most impact on reducing disparities is critical. METHODS: Using available US Centers for Disease Control and Prevention (CDC) estimates, we constructed HIV care continua for black and white MSM for 2009-2010. These estimates were used as parameters in a deterministic model to yield estimated race-specific transmissions, transmission rates, incidence rates, and rate-ratios (RR). We examined the impact of changes in the care continuum for black MSM on transmission and incidence rates. FINDINGS: Marked disparities were found throughout the care continuum: ultimately, 16% of black and 34% of white MSM achieved viral suppression. Based on these care continua, 9,833 and 9,710 new HIV transmissions were estimated annually respectively from HIV-positive black and white MSM (transmission RR=1·36 and incidence RR=7·92). In a model where black and white MSM have identical care outcomes, transmission RR=1·00 and incidence RR=5·80. Scenarios of 95% diagnosis, 95% retention, and concurrent 95% diagnosis and 95% retention respectively yield transmission RR=1·00, 1·02, 0·56, and incidence RR=5·81, 5·93, 3·28. INTERPRETATION: Disparities in HIV transmission rates may be reduced by improving the HIV care continuum outcomes, but existing racial disparities in HIV prevalence will likely continue to drive higher incidence among black MSM for decades to come.
Authors: Gregorio A Millett; John L Peterson; Stephen A Flores; Trevor A Hart; William L Jeffries; Patrick A Wilson; Sean B Rourke; Charles M Heilig; Jonathan Elford; Kevin A Fenton; Robert S Remis Journal: Lancet Date: 2012-07-20 Impact factor: 79.321
Authors: Patrick S Sullivan; Alex Carballo-Diéguez; Thomas Coates; Steven M Goodreau; Ian McGowan; Eduard J Sanders; Adrian Smith; Prabuddhagopal Goswami; Jorge Sanchez Journal: Lancet Date: 2012-07-20 Impact factor: 79.321
Authors: Edward M Gardner; Margaret P McLees; John F Steiner; Carlos Del Rio; William J Burman Journal: Clin Infect Dis Date: 2011-03-15 Impact factor: 9.079
Authors: Beryl A Koblin; Marla J Husnik; Grant Colfax; Yijian Huang; Maria Madison; Kenneth Mayer; Patrick J Barresi; Thomas J Coates; Margaret A Chesney; Susan Buchbinder Journal: AIDS Date: 2006-03-21 Impact factor: 4.177
Authors: Gary Marks; Gregorio A Millett; Trista Bingham; Lisa Bond; Jennifer Lauby; Adrian Liau; Christopher S Murrill; Ann Stueve Journal: AIDS Behav Date: 2008-08-28
Authors: Frangiscos Sifakis; John B Hylton; Colin Flynn; Liza Solomon; Duncan A Mackellar; Linda A Valleroy; David D Celentano Journal: J Acquir Immune Defic Syndr Date: 2007-11-01 Impact factor: 3.731
Authors: Colleen F Kelley; Eli S Rosenberg; Brandon M O'Hara; Paula M Frew; Travis Sanchez; John L Peterson; Carlos Del Rio; Patrick S Sullivan Journal: PLoS One Date: 2012-12-28 Impact factor: 3.240
Authors: Anthony J James; Danelle Marable; Caroline V Cubbison; Andrew A Tarbox; Dianna L Mejia; Sarah A Oo; Kenneth A Freedberg; Julie H Levison Journal: AIDS Care Date: 2019-05-27
Authors: Philip A Chan; Jennifer Rose; Justine Maher; Stacey Benben; Kristen Pfeiffer; Alexi Almonte; Joanna Poceta; Catherine E Oldenburg; Sharon Parker; Brandon Dl Marshall; Mickey Lally; Kenneth Mayer; Leandro Mena; Rupa Patel; Amy S Nunn Journal: AIDS Patient Care STDS Date: 2015-09-21 Impact factor: 5.078
Authors: Steven M Goodreau; Eli S Rosenberg; Samuel M Jenness; Nicole Luisi; Sarah E Stansfield; Gregorio A Millett; Patrick S Sullivan Journal: Lancet HIV Date: 2017-04-18 Impact factor: 12.767
Authors: John A Schneider; Michael Kozloski; Stuart Michaels; Britt Skaathun; Dexter Voisin; Nicola Lancki; Ethan Morgan; Aditya Khanna; Keith Green; Robert W Coombs; Samuel R Friedman; Edward Laumann; Phil Schumm Journal: AIDS Date: 2017-01-02 Impact factor: 4.177
Authors: Brandon D L Marshall; William C Goedel; Maximilian R F King; Alyson Singleton; David P Durham; Philip A Chan; Jeffrey P Townsend; Alison P Galvani Journal: Lancet HIV Date: 2018-06-13 Impact factor: 12.767
Authors: Alyson L Singleton; Brandon D L Marshall; Xiao Zang; Amy S Nunn; William C Goedel Journal: AIDS Patient Care STDS Date: 2020-11-19 Impact factor: 5.078